Abstract | BACKGROUND: MATERIALS AND METHODS: ONE HUNDRED THIRTY TWO PARTURIENTS WERE RANDOMLY ALLOCATED TO ONE OF THREE GROUPS: group M (n = 44) that received intravenous midazoalm 30 μg/kg; group O (n = 44) that received intravenous ondansetron 8 mg; group MO (n = 44) that received intravenous midazoalm 30 μg/kg combined with intravenous ondansetron 8 mg if patients had vomiting or VAS of nausea ≥ 3 during surgery (after umbilical cord clamping) and 24 hours after that. The incidence and severity of vomiting episodes and nausea with visual analog scale (VAS) > 3 were evaluated at 2 hours, 6 hours, and 24 hours after injection of study drugs. RESULTS: The incidence of nausea was significantly less in group MO compared with group M and group O at 6 hours postoperatively (P = 0.01). This variable was not significantly different in three groups at 2 hours and 24 hours after operation. The severity of nausea and vomiting was significantly different in three groups at 6 hours after operation (P < 0.05). CONCLUSION:
|
Authors | Mitra Jabalameli, Azim Honarmand, Mohammadreza Safavi, Mohsen Chitsaz |
Journal | Advanced biomedical research
(Adv Biomed Res)
Vol. 1
Pg. 2
( 2012)
ISSN: 2277-9175 [Print] India |
PMID | 23210061
(Publication Type: Journal Article)
|